The FDA will hold a meeting to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement Stevens & Lee When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions